Compassionate 发表于 2025-3-28 15:20:47
http://reply.papertrans.cn/59/5803/580296/580296_41.png边缘带来墨水 发表于 2025-3-28 19:23:13
http://reply.papertrans.cn/59/5803/580296/580296_42.pngMerited 发表于 2025-3-29 02:22:16
http://reply.papertrans.cn/59/5803/580296/580296_43.pngFLAG 发表于 2025-3-29 04:02:49
http://reply.papertrans.cn/59/5803/580296/580296_44.pnginsomnia 发表于 2025-3-29 11:07:34
http://reply.papertrans.cn/59/5803/580296/580296_45.png我正派 发表于 2025-3-29 15:16:08
http://reply.papertrans.cn/59/5803/580296/580296_46.pngIntruder 发表于 2025-3-29 19:32:22
http://reply.papertrans.cn/59/5803/580296/580296_47.png注意力集中 发表于 2025-3-29 21:39:18
Collection of Coagulation Specimens, hemostasis testing. The purpose of this chapter is to describe current recommendations for and points of ambiguity about specimens for hemostasis testing to assist the laboratory director in establishing standard operating procedures and evaluating the acceptability of non-ideal specimens.wangle 发表于 2025-3-30 00:49:49
Instrumentation for the Coagulation Laboratory,es. For a current summary of marketed devices, the reader is referred to the annual College of American Pathologists summary list of laboratory-based coagulation analyzers and their attributes published on the College’s web site (.). A separate list of point of care analyzers can also be found on the site.长处 发表于 2025-3-30 05:44:08
Testing for Inherited Bleeding Disorders,tain inherited thrombotic disorders that are associated with highly-conserved point mutations (e.g., factor V Leiden), the inherited bleeding disorders are polygenic and are best diagnosed with functional coagulation assays. All assays discussed in this chapter have FDA approval except for the quantitative factor XIII assay.